9 completed, 4 unknown, 3 active not recruiting, 3 terminated. 19 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 19 | Completed 9, Unknown 4, Active not recruiting 3, Terminated 3 |
| Phase 2 | 4 | Terminated 2, Active not recruiting 1, Completed 1 |
Follow NAC: new trials by email Literature Review of NAC trials Research Report on NAC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Combined Effect of N-Acetyl Cysteine and Metformin in Polycystic Ovary Syndrome Patients N-acetyl cysteine, Metfomin - Polycystic Ovary Syndrome | Phase 3 | Completed | Cairo University | 102 | 2025-03-01 | 2026-10-21 |
| Safety and Efficacy of N-Acetylcysteine Mouthwash in Prevention of Mucositis in HSCT Patients N-Acetylcysteine 600mg/tab, Placebo - Oral Mucositis, Hematopoietic Stem Cell Transplantation (HSCT) | Phase 3 | Active not recruiting | Tehran University of Medical Sciences | 106 | 2024-08-18 | 2026-01-08 |
| NAC vs Placebo on Opioid Use for Hysterectomy IV N-acetylcysteine, IV Placebo - Hysterectomy | Phase 3 | Completed | Medical University of South Carolina | 240 | 2023-11-30 | 2026-10-09 |
| The Use of N-acetylcysteine for Thrombotic Events After Allogenic Hematopoietic Stem Cell Transplantation N-acetyl-cysteine, Busulfan, Cytarabine - Thrombotic Disorder | Phase 3 | Unknown | The First Affiliated Hospital of Soochow University | 260 | 2023-08-01 | 2023-06-18 |
| A Pan-TB Regimen Targeting Host and Microbe Sutezolid, N-acetyl cysteine, Pretomanid - Tuberculosis | Phase 2 / Phase 3 | Active not recruiting | The Aurum Institute NPC | 352 | 2023-07-28 | 2025-05-28 |
| Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial N-acetyl cysteine, Placebo - Idiopathic Pulmonary Fibrosis | Phase 3 | Completed | Fernando J Martinez | 202 | 2020-12-17 | 2026-03-20 |
| Inflammatory Regulation Effect of NAC on COVID-19 Treatment N-Acetyl cysteine, Placebo - COVID-19 | Phase 3 | Unknown | Dr. Tariq Alhawassi | 1180 | 2020-08-01 | 2020-07-21 |
| Correction of Neonatal Glutathione by N-acetylcysteine in Pregnant Women at Risk of Premature Birth (GSH MAP) N-acetylcysteine, Placebo - Preterm Delivery | Phase 2 / Phase 3 | Terminated | Nantes University Hospital | 39 | 2018-11-05 | 2022-12-19 |
| Risk Stratification-directed NAC for Prevention of Poor Hematopoietic Reconstitution N-acetyl-L-cysteine - Stem Cell Transplant Complications | Phase 3 | Unknown | Peking University People's Hospital | 130 | 2018-10-01 | 2021-09-14 |
| A Safety and Efficacy Study of NAC in Patients With TA-TMA N-Acetylcysteine, Placebo Oral Tablet - Thrombotic Microangiopathies, Hematologic Diseases | Phase 3 | Completed | The First Affiliated Hospital of Soochow University | 170 | 2017-11-01 | 2022-02-14 |
| "Multimodal Prevention of Psychosis - Investigating Efficacy of N-Acetylcysteine and Psychotherapy in CHR-Patients" N-Acetylcysteine, Placebo, IPPI (Integrated Preventive Psychological Intervention) - Prodromal Schizophrenia | Phase 3 | Terminated | University Hospital, Bonn | 48 | 2016-09-01 | 2022-05-09 |
| N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic Hepatitis N-acetyl cysteine (NAC) - Alcoholic Hepatitis, Infection | Phase 3 | Unknown | Imperial College London | 42 | 2015-10-01 | 2021-11-09 |
| NAC Effect on Hox Genes Expressions in RIF N-acetyl cysteine, Placebos - Female Infertility | Phase 3 | Completed | Royan Institute | 40 | 2015-02-01 | 2019-03-05 |
| Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment N-Acetylcysteine, Placebo - Cannabis Dependence | Phase 3 | Completed | Medical University of South Carolina | 302 | 2014-01-01 | 2018-05-24 |
| Prevention of Serious Adverse Events Following Angiography IV isotonic saline, IV isotonic bicarbonate, N-acetylcysteine - Acute Renal Failure, Kidney Disease | Phase 3 | Completed | VA Office of Research and Development | 5177 | 2013-10-07 | 2025-11-05 |
| Use of N-Acetylcysteine (NAC) in Fingernail Biting N-Acetylcysteine (NAC), Placebo - Onychophagia | Phase 3 | Completed | Kevin Gray, MD | 23 | 2013-10-01 | 2018-10-03 |
| Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention NAC, Saline - Acute ST Segment Elevation Myocardial Infarction | Phase 3 | Active not recruiting | Suleyman Demirel University | 100 | 2013-01-01 | 2025-05-20 |
| A Clinical Trial for CTD-ILD Treatment N-Acetylcysteine - Interstitial Lung Disease, Connective Tissue Disease | Phase 2 / Phase 3 | Terminated | University of Michigan | 5 | 2011-12-01 | 2017-04-06 |
| Protective Effect of N-acetylcysteine Against From Ototoxicity N-acetylcysteine - Hearing Loss, Extreme | Phase 2 / Phase 3 | Completed | TC Erciyes University | 60 | 2010-06-01 | 2011-11-16 |
Acute Kidney Injury (1) · Anxiety Disorders (1) · Arthritis, Rheumatoid (1) · Attention Deficit Disorder with Hyperactivity (1) · COVID-19 (1) · Connective Tissue Diseases (1) · Coronary Artery Disease (1) · Deafness (1) · Depression (1) · Dermatomyositis (1) · Hematologic Diseases (1) · Hepatitis, Alcoholic (1) · Idiopathic Pulmonary Fibrosis (1) · Infections (1) · Infertility, Female (1)
Medical University of South Carolina (2) · The First Affiliated Hospital of Soochow University (2) · Cairo University (1) · Dr. Tariq Alhawassi (1) · Fernando J Martinez (1) · Imperial College London (1) · Kevin Gray, MD (1) · Nantes University Hospital (1) · Peking University People's Hospital (1) · Royan Institute (1) · Suleyman Demirel University (1) · TC Erciyes University (1) · Tehran University of Medical Sciences (1) · The Aurum Institute NPC (1) · University Hospital, Bonn (1)
United States (6) · China (2) · Turkey (Türkiye) (2) · Australia (1) · Egypt (1) · France (1) · Germany (1) · Iran (1) · Malaysia (1) · Mozambique (1) · New Zealand (1) · South Africa (1) · Tanzania (1) · United Kingdom (1)
Kevin M Gray, MD (2) · Amr Z Abdelhamid, PhD (1) · Ashraf Moini, MD (1) · Cathie Spino, ScD (1) · Depei Wu, MD. PhD. (1) · Eglal A Mostafa Bassiouny, PhD (1) · Fernando J Martinez, MD (1) · Imre Noth, MD (1) · Ismail Kocyigit, MD (1) · Kevin Flaherty, MS, MD (1) · Mark Thursz, MD (1) · Maryam Shahhoseini, PhD (1) · Parvaneh Afsharian, PhD (1) · Professor Robert Wallis, MD (1)
PMID 25073872, PMID 26860769, PMID 28623823, PMID 28847455, PMID 29130810, PMID 31712969, PMID 34197135, PMID 35084903, PMID 35473809, PMID 36514019, PMID 41749341, PMID 42829889
U10DA013045 (1), U10DA013727 (1), U10DA013732 (1), U10DA015815 (1), U10DA015831 (1), U10DA020024 (1), U24HL145265 (1), UG1DA013727 (1)